It was also reported in a recent study that the TrkA inhibitors GW441756, K252a, CEP‐701, and Gö6976 promote the effects of agents that induce ROS‐mediated death in neuroblastoma cells (Ruggeri et al., 2014). The gene discussed is NTRK1; the disease is neuroblastoma.